top of page
Latest Breakthrough

Engineered Stem Cells Without Immunosuppression

How Sana Biotechnology is reimagining islet cell transplantation for people with Type 1 Diabetes.

Discover how Sana Biotechnology is developing genetically engineered islet cells designed to avoid immune detection—bringing researchers one step closer to making stem cell-based therapies safer and more accessible by potentially eliminating the need for lifelong immunosuppressive medications.

Research Digest

We translate the latest complex medical studies into simple insights, helping you stay informed about the breakthroughs that matter to your T1D journey.

The First Drug to Change the Course of Type 1 Diabetes:  Teplizumab (Tzield)

Teplizumab is the first treatment shown to slow the progression of Type 1 Diabetes by targeting the immune system. Learn how this groundbreaking therapy is changing the future of diabetes care.

Stem Cell Therapy That Has Helped Some People Live Without Insulin

Vertex is developing a stem cell–derived islet cell therapy that replaces insulin-producing cells lost in Type 1 Diabetes. In clinical trials, some participants have reduced or stopped insulin use. Learn how this breakthrough is advancing the search for a functional cure for Type 1 Diabetes.

Exercise & Glycemic Control

How high-intensity intervals versus steady cardio affect blood sugar recovery in student athletes.

Future articles and resources will be added here...

Further Reading & Resources

Explore credible medical sources and foundations dedicated to supporting T1D teens and their families. We've curated these links to help you find the most accurate and up-to-date information.

JDRF International

The leading global organization funding type 1 diabetes (T1D) research.

Beyond Type 1

Resources, stories, and programs for those living with T1D.

American Diabetes Assoc.

Comprehensive medical information and advocacy for the diabetes community.

bottom of page